9988:HKEXAlibaba Group Holding Limited Analysis
Data as of 2026-07-27 - not real-time
HK$109.90
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Alibaba (9988.HK) trades well above its 20‑day and 50‑day simple moving averages, with the price hovering near the 20‑day SMA but still below the 200‑day SMA, indicating a longer‑term bearish bias. The RSI sits just under the neutral 50 mark, and the MACD shows a bullish histogram despite an overall bearish trend and decreasing volume, suggesting mixed short‑term momentum. Fundamentally, revenue is still growing modestly and forward earnings estimates are improving, yet the DCF‑derived fair value is far below the current market price, creating a substantial valuation gap.
The company carries a high debt load relative to equity and negative free cash flow, which raises concerns about dividend sustainability despite a modest payout. High 30‑day volatility and a “Extreme Greed” sentiment index add to the near‑term risk, while regulatory scrutiny in China and concentration in the Chinese market heighten sector and geographic risks.
The company carries a high debt load relative to equity and negative free cash flow, which raises concerns about dividend sustainability despite a modest payout. High 30‑day volatility and a “Extreme Greed” sentiment index add to the near‑term risk, while regulatory scrutiny in China and concentration in the Chinese market heighten sector and geographic risks.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish longer‑term trend with price below 200‑day SMA
- Mixed technical signals (bullish MACD vs decreasing volume)
- Significant valuation premium over DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Steady revenue growth and improving forward EPS
- Strong cash reserves offsetting high debt levels
- Potential easing of regulatory pressure in China
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic position in e‑commerce and cloud services
- Long‑term growth opportunities in international markets
- Resilient business model despite short‑term valuation stretch
Key Metrics & Analysis
Financial Health
Revenue Growth2.90%
Profit Margin10.12%
P/E Ratio17.3
ROE9.22%
ROA2.12%
Debt/Equity25.01
P/B Ratio1.7
Op. Cash FlowHK$76.2B
Free Cash FlowHK$-44074250240
Technical Analysis
TrendBearish
RSI49.5
SupportHK$91.15
ResistanceHK$121.00
MA 20HK$106.93
MA 50HK$113.21
MA 200HK$140.03
MACDBullish
VolumeDecreasing
Fear & Greed Index88.25
Valuation
Fair ValueHK$42.07
Target PriceHK$181.09
Upside/Downside64.78%
GradeOvervalued
TypeGrowth
Dividend Yield0.94%
Risk Assessment
Beta0.69
Volatility52.79%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
601398
Industrial and Commercial Bank of China Limited Class A
STOCK601898
China Coal Energy Co. Ltd. Class A
STOCK002648
Satellite Chemical Co. Ltd. Class A
STOCK601668
China State Construction Engineering Corp. Ltd. Class A
STOCK600919
Bank of Jiangsu Co., Ltd. Class A
STOCK002050
Zhejiang Sanhua Intelligent Controls Co.,Ltd
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.